CHELT Therapy cryotherapy uses dry cold air at -40°C while monitoring and controlling the patient's tissue temperature. It causes strong superficial and deep vasoconstriction that slows cell metabolism, generates intense reactive hyperemia and reduces the conduction speed of nerve fibers. These benefits enhance the anti-inflammatory action, biostimulation and analgesic effect respectively.
CHELT Therapy generates thermal shocks of 95°C in less than 1 second with thermal control of the treated biological tissue and activates an intense vascular workout generated by the synergistic effect of cryotherapy and dry air thermotherapy.
This vascular training accelerates the natural healing process, reduces pain sensations and enhances anti-inflammatory action.
Cryotherapy at -40°C limits blood extravasation and allows early instrumental investigations to identify the best therapeutic strategy and achieve rapid functional recovery. In addition, the correct dose that THEAL Therapy PBM brings to the tissues, anticipates rehabilitation and accelerates healing.
Thanks to superficial vasoconstriction, the laser beam can continuously reach the deepest layers of tissue, thus achieving tangible results more quickly.